GSK3527497 is a potent and selective inhibitor of Transient Receptor Potential Vanilloid-4 (TRPV4) with IC50 = 12 nM) for the treatment of heart failure and respiratory diseases. GSK3527497 is a preclinical candidate suitable for oral and iv administration that is projected to inhibit TRPV4 effectively in patients from a low daily clinical dose.
Molekulargewicht:
463.3054
CAS Nummer:
[2215855-51-7]
Formel:
C17H17Cl2FN4O4S
Target-Kategorie:
Others
T69784
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten